Palantza Polyxeni Tou Konstantinou
Palantza Polyxeni Tou Konstantinou is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A randomized, double-blind, placebo-controlled pragmatic study to evaluate FINerenone on clinicAL effIcacy and safeTY in patients with Heart Failure and reduced ejection fraction who are intolerant of or not eligible for treatment with steroidal mineralocorticoid receptor antagonists (FINALITY-HF)
Sponsor Colorado Prevention Center
- Start (EU)
- Latest update
- Estimated end
IMpAct of CardiolRxTM oVer 6 months following IL-1 Blocker cessation in pERICarditis patients – MAVERIC: A randomized, double-blind, placebo-controlled trial
Sponsor Cardiol Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Palantza Polyxeni Tou Konstantinou?
The 2026-10-09 snapshot links Palantza Polyxeni Tou Konstantinou to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Investigator recruitment, Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Palantza Polyxeni Tou Konstantinou?
The most frequently recorded therapeutic areas are Cardiology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Palantza Polyxeni Tou Konstantinou conducted?
The linked trials record locations in 7 countries, including Greece, Italy, Czechia, Spain, Croatia. These are trial locations, not confirmed office locations or countries where Palantza Polyxeni Tou Konstantinou delivered services.
What can this page tell me about Palantza Polyxeni Tou Konstantinou's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Palantza Polyxeni Tou Konstantinou. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Palantza Polyxeni Tou Konstantinou